October 16, 2019 / 6:55 AM / 2 months ago

BRIEF-Roche CEO does not expect U.S. to slap tariffs on European drugs

Oct 16 (Reuters) - Roche Holding AG:

* CEO SAYS BELIEVES CONCERNS, REPORTS ABOUT U.S. TARIFFS IMPACT ON SWISS DRUGMAKERS ‘BASED ON WRONG FACTS’

* DRUGS DIVISION HEAD SAYS CHINA SALES HAVE GROWN MORE THAN 50% THIS YEAR, BELIEVES THIS YEAR “HIGH WATER MARK” FOR GROWT RATE

* CEO SAYS BIOSIMILARS IMPACT IS “IN LINE” WITH EXPECTATIONS

* DRUGS DIVISION HEAD SAYS CHINESE GROWTH COMES AS MABTHERA, HERCEPTIN EXPANDED GEOGRAPHICALLY INTO RURAL AREAS, BUT THAT “GREATER THAN 50%” GROWTH IS HARD TO ACHIEVE

* DRUGS DIVISION CHIEF EXPECTS SIGNIFICANT UPTAKE OF BIOSIMILARS IN UNITED STATES, BUT HAS NOT HAPPENED YET

* DRUGS DIVISION HEAD SAYS OPTIMISTIC ABOUT EUROPEAN GROWTH PROSPECTS FOLLOWING BIOSIMILARS IMPACT, “THE OUTLOOK IS VERY STRONG FOR EUROPE”

* CEO SAYS HAS NO EXPECTATION THAT UNITED STATES WILL IMPOSE TARIFFS ON PHARMACEUTICAL PRODUCTS FROM EUROPE Source text for Eikon: Further company coverage: (Reporting by John Miller)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below